NexMed shares sink on Novartis decision (AP via Yahoo! Finance)
Drug developer NexMed Inc. said Tuesday that its development partner, Swiss drug maker Novartis AG, has decided not to submit a new drug application for an experimental nail fungus treatment to the Food and Drug Administration at this time.